- Corporate Officers - I
- Ingram Douglas S
Insider Trading History of Ingram Douglas S
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Ingram Douglas S since 2006.
This trader's CIK number is 1190644.
At the time of last reporting, Ingram Douglas S was the President & CEO of Sarepta Therapeutics, Inc.. (stock ticker symbol SRPT).
Also see all insider trading activities at Sarepta Therapeutics, Inc..
Note that in the past
INGRAM DOUGLAS S also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Allergan Inc (AGN) by Ingram Douglas S
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2014 | AGN | 0 | $0 | 84,000 | $10,449,432 | 84,000 | $4,701,900 |
| 2012 | AGN | 0 | $0 | 166,000 | $14,278,950 | 166,000 | $6,336,840 |
| 2009 | AGN | 0 | $0 | 60,204 | $3,398,816 | 60,204 | $1,405,582 |
| 2008 | AGN | 0 | $0 | 13,936 | $561,188 | 22,420 | $374,257 |
| 2007 | AGN | 0 | $0 | 14,994 | $993,926 | 14,994 | $127,859 |
| 2006 | AGN | 0 | $0 | 30,362 | $3,644,350 | 30,362 | $2,103,661 |
Yearly summary of insider trading at Relay Therapeutics, Inc. (RLAY) by Ingram Douglas S
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | RLAY | 25,000 | $500,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Volcom Inc (VLCM) by Ingram Douglas S
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2006 | VLCM | 2,500 | $48,137 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Sarepta Therapeutics, Inc. (SRPT) by Ingram Douglas S
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | SRPT | 25,225 | $2,017,117 | 0 | $0 | 0 | $0 |
| 2021 | SRPT | 25,026 | $2,000,578 | 0 | $0 | 0 | $0 |
| 2019 | SRPT | 16,252 | $2,000,377 | 0 | $0 | 0 | $0 |
| 2018 | SRPT | 32,695 | $4,017,625 | 0 | $0 | 0 | $0 |
| 2017 | SRPT | 85,196 | $3,999,921 | 0 | $0 | 0 | $0 |
Insider trading activities at 4 companies by Ingram Douglas S:
1. Allergan Inc (AGN)
2. Relay Therapeutics, Inc. (RLAY)
3. Volcom Inc (VLCM)
4. Sarepta Therapeutics, Inc. (SRPT)
Table 1. Insider trading of Allergan Inc (AGN) by Ingram Douglas S
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2014-02-21 | AGN | Sale | 0 | 125.70 | 0 |
| 2014-02-14 | AGN | Option Ex | 84,000 | 55.98 | 4,701,900 |
| 2014-02-14 | AGN | Sale | 84,000 | 124.40 | 10,449,432 |
| 2012-08-30 | AGN | Option Ex | 100,000 | 36.15 | 3,615,000 |
| 2012-08-30 | AGN | Sale | 100,000 | 85.78 | 8,578,200 |
| 2012-02-07 | AGN | Option Ex | 66,000 | 41.24 | 2,721,840 |
| 2012-02-07 | AGN | Sale | 66,000 | 86.38 | 5,700,750 |
| 2009-11-03 | AGN | Option Ex | 60,204 | 23.35 | 1,405,582 |
| 2009-11-03 | AGN | Sale | 60,204 | 56.45 | 3,398,816 |
| 2008-12-08 | AGN | Sale | 13,936 | 40.27 | 561,188 |
| 2008-12-08 | AGN | Option Ex | 22,420 | 16.69 | 374,257 |
| 2007-11-30 | AGN | Sale | 13,846 | 66.32 | 918,266 |
| 2007-11-29 | AGN | Sale | 1,100 | 66.00 | 72,600 |
| 2007-11-30 | AGN | Option Ex | 13,846 | 8.35 | 115,614 |
| 2007-11-29 | AGN | Option Ex | 1,100 | 8.35 | 9,185 |
| 2007-07-23 | AGN | Option Ex | 48 | 63.75 | 3,060 |
| 2007-07-23 | AGN | Sale | 48 | 63.76 | 3,060 |
| 2006-11-20 | AGN | Option Ex | 30,362 | 69.29 | 2,103,661 |
| 2006-11-20 | AGN | Sale | 30,362 | 120.03 | 3,644,350 |
Table 2. Insider trading of Relay Therapeutics, Inc. (RLAY) by Ingram Douglas S
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-07-20 | RLAY | Buy | 25,000 | 20.00 | 500,000 |
Table 3. Insider trading of Volcom Inc (VLCM) by Ingram Douglas S
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2006-08-03 | VLCM | Buy | 2,500 | 19.25 | 48,137 |
Table 4. Insider trading of Sarepta Therapeutics, Inc. (SRPT) by Ingram Douglas S
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-11-03 | SRPT | Buy | 25,225 | 79.97 | 2,017,117 |
| 2021-11-17 | SRPT | Buy | 25,026 | 79.94 | 2,000,578 |
| 2019-08-12 | SRPT | Buy | 16,252 | 123.08 | 2,000,377 |
| 2018-10-30 | SRPT | Buy | 16,695 | 120.60 | 2,013,417 |
| 2018-08-15 | SRPT | Buy | 16,000 | 125.26 | 2,004,208 |
| 2017-11-08 | SRPT | Buy | 38,138 | 52.44 | 1,999,956 |
| 2017-07-27 | SRPT | Buy | 47,058 | 42.50 | 1,999,965 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Ingram Douglas S
(President & CEO of Sarepta Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.